Evidence map›Paper›PMID 30627312›Full record

ArticleThe Pan African medical journal2018

[Cardiovascular and metabolic impact of glucocorticoid substitution therapy in patients with Addison's disease].

Dhoha Ben Salah, Nadia Charfi, Mouna Elleuch, Faten Hadj Kacem, Nabila Rekik, Mouna Mnif, Fatma Mnif, Mohamed Abid

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dhoha Ben SalahService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Nadia CharfiService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Mouna ElleuchService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Faten Hadj KacemService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Nabila RekikService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Mouna MnifService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Fatma MnifService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Mohamed AbidService d'Endocrinologie et Diabétologie du CHU Hédi Chaker Sfax, Tunisie.
Hopital Universitaire Hedi Chaker · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies conducted in patients with Addison's disease (AD) highlighted that this disease, even after treatment, is a significant cause of morbi-mortality. This study aims to determine the cardiovascular and metabolic deleterious impact of long-course glucocorticoid substitution therapy. We conducted a retrospective study of 28 patients with treated Addison's disease evolving for more than 15 years. The average age of patients was 58, 53 years, with a female predominance (65%). The average follow-up period was 17, 87 years. Initial dose of hydrocortisone was 32, 5 mg/day (20.52 mg/m

Indexed as

Addison DiseaseAdultAgedAged, 80 and overDiabetes Mellitus, Type 2Dose-Response Relationship, DrugDyslipidemiasFemaleFollow-Up StudiesGlucocorticoidsHormone Replacement TherapyHumansHydrocortisoneHypertensionMaleMetabolic SyndromeGlucocorticoidsHydrocortisoneAddison’s diseasecardiovascular riskhydrocortisonemetabolic syndromemorbidity

Identifiers

PMID30627312
PMCPMC6307925
OpenAlexW2887260624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.